H.R. 2820: Stem Cell Therapeutic and Research Reauthorization Act of 2015

To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.

The federal budget process occurs in two stages: appropriations, which set overall spending limits by agency or program, and authorizations, which direct how federal funds should (or should not) be used. Appropriation and authorization provisions are typically made for single fiscal years. A reauthorization bill like this one renews the authorizations of an expiring law.



Jun 18, 2015
114th Congress, 2015–2017


Enacted — Signed by the President on Dec 18, 2015

This bill was enacted after being signed by the President on December 18, 2015.


Pub.L. 114-104


Christopher “Chris” Smith

Representative for New Jersey's 4th congressional district



Read Text »
Last Updated: Oct 6, 2016
Length: 3 pages


Jun 18, 2015

This is the first step in the legislative process.

Jul 29, 2015
Reported by Committee

A committee has issued a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.

Sep 8, 2015
Passed House

The bill was passed in a vote in the House. It goes to the Senate next. The vote was by voice vote so no record of individual votes was made.

Dec 3, 2015
Text Published

Updated bill text was published as of Reported by Senate Committee.

Dec 9, 2015
Passed Senate with Changes

The Senate passed the bill with changes not in the House version and sent it back to the House to approve the changes. The vote was by Unanimous Consent so no record of individual votes was made.

Dec 16, 2015
House Agreed to Changes

The bill was passed by both chambers in identical form. It goes to the President next who may sign or veto the bill.

Dec 18, 2015
Enacted — Signed by the President

The President signed the bill and it became law.

H.R. 2820 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“H.R. 2820 — 114th Congress: Stem Cell Therapeutic and Research Reauthorization Act of 2015.” www.GovTrack.us. 2015. October 25, 2016 <https://www.govtrack.us/congress/bills/114/hr2820>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.